TFGT
TS Financial Group (TSFG)’s Harvard Bioscience HBIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $0 | Hold |
300
| – | – | ﹤0.01% | 836 |
|
|
2025
Q1 | $0 | Hold |
300
| – | – | ﹤0.01% | 825 |
|
|
2024
Q4 | $1K | Hold |
300
| – | – | ﹤0.01% | 704 |
|
|
2024
Q3 | $1K | Hold |
300
| – | – | ﹤0.01% | 732 |
|
|
2024
Q2 | $1K | Hold |
300
| – | – | ﹤0.01% | 724 |
|
|
2024
Q1 | $1K | Hold |
300
| – | – | ﹤0.01% | 721 |
|
|
2023
Q4 | $2K | Hold |
300
| – | – | ﹤0.01% | 730 |
|
|
2023
Q3 | $1K | Hold |
300
| – | – | ﹤0.01% | 950 |
|
|
2023
Q2 | $2K | Hold |
300
| – | – | ﹤0.01% | 828 |
|
|
2023
Q1 | $1K | Sell |
300
-200
| -40% | -$667 | ﹤0.01% | 897 |
|
|
2022
Q4 | $1K | Hold |
500
| – | – | ﹤0.01% | 914 |
|
|
2022
Q3 | $1K | Hold |
500
| – | – | ﹤0.01% | 887 |
|
|
2022
Q2 | $2K | Hold |
500
| – | – | ﹤0.01% | 797 |
|
|
2022
Q1 | $3K | Hold |
500
| – | – | ﹤0.01% | 714 |
|
|
2021
Q4 | $4K | Hold |
500
| – | – | ﹤0.01% | 685 |
|
|
2021
Q3 | $3K | Hold |
500
| – | – | ﹤0.01% | 704 |
|
|
2021
Q2 | $4K | Buy |
500
+200
| +67% | +$1.6K | ﹤0.01% | 671 |
|
|
2021
Q1 | $2K | Hold |
300
| – | – | ﹤0.01% | 677 |
|
|
2020
Q4 | $1K | Hold |
300
| – | – | ﹤0.01% | 839 |
|
|
2020
Q3 | $1K | Hold |
300
| – | – | ﹤0.01% | 756 |
|
|
2020
Q2 | $1K | Hold |
300
| – | – | ﹤0.01% | 758 |
|
|
2020
Q1 | $1K | Hold |
300
| – | – | ﹤0.01% | 710 |
|
|
2019
Q4 | $1K | Hold |
300
| – | – | ﹤0.01% | 728 |
|
|
2019
Q3 | $1K | Hold |
300
| – | – | ﹤0.01% | 720 |
|
|
2019
Q2 | $1K | Hold |
300
| – | – | ﹤0.01% | 695 |
|
|
2019
Q1 | $1K | Buy |
+300
| New | +$1K | ﹤0.01% | 684 |
|